About
Corneal disease therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
6,738
By Phase
NA: 2
By Status
RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
2052
2053
2054
2055
2056
Today
Hover over trial bars to see details
Recent Trials
NCT04310098Lead Sponsor
CADASIL Registry Study
N/ARecruiting
1,000 participants
Started: Mar 9, 2020 · Completed: Mar 9, 2049
NCT04318119Lead Sponsor
Cerebral Small Vessel Disease Registry Study
N/ARecruiting
3,000 participants
Started: Nov 18, 2019 · Completed: Nov 18, 2055
NCT03146897Collaborator
Comparison of Four Different Supplementary Foods in the Treatment of Moderate Acute Malnutrition
NACompleted
2,691 participants
Started: Apr 11, 2017 · Completed: Nov 24, 2018
NCT02029521Lead Sponsor
Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis Patients
NACompleted
47 participants
Started: Mar 31, 2011 · Completed: Jul 31, 2012
Locations (1)
Headquarters
Jersey City, NJ, United States
Map
Loading map...